Ocular Inflammation Treatment Market is Projected to Reach Valuation of US$ 530 Million by 2026

Ocular Inflammation Treatment Market Segmentation by Treatment Type Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosuppressant, Cycloplegic Agents, Antivirals; Disease Type - Anterior Uveitis, Posterior Uveitis, Panuveitis, Intermediate Uveitis; Mode of Administration Topical, Injectables, Oral, and Others; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores, and Forecast 2017-2026

Š2019 Transparency Market Research, All Rights Reserved

Sr. No.

Content

Chapter 1

Preface

Chapter 2

Assumptions and Research Methodology

Chapter 3

Market Overview

Chapter 4

Market Dynamics

Chapter 5

Global Ocular Inflammation Treatment Market Analysis and Forecasts, By Software Type

Chapter 6

Global Ocular Inflammation Treatment Market Analysis, by Modality

Chapter 7

Global Ocular Inflammation Treatment Market Analysis, by Application

Chapter 8

Global Ocular Inflammation Treatment Market Analysis, by End-user

Chapter 9

Global Ocular Inflammation Treatment Market Analysis and Forecast by Region

Chapter 10

Europe Ocular Inflammation Treatment Market Analysis and Forecast

Chapter 11

Asia Pacific Ocular Inflammation Treatment Market Analysis and Forecast

Chapter 12

Latin America Ocular Inflammation Treatment Market Analysis and Forecast

Chapter 13

Middle East & Africa Ocular Inflammation Treatment Market Analysis and Forecast

Chapter 14

Competition Landscape

Š2019 Transparency Market Research, All Rights Reserved



Eye inflammations or uveitis are becoming a common problem for people across global geographies.



New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines.



Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.



The global market for ocular inflammation treatment is expected to grow sharply in the coming years.

©2019 Transparency Market Research, All Rights Reserved



Key projections from the study assess the global ocular inflammation treatment market to touch a US$ 1 billion value by the end of 2026.



Increasing contamination of environment by emission of toxins has elevated the risks of ocular inflammation, also known as uveitis.



Evolving medical technologies and drug discovery developments have paved way for effective treatment of ocular inflammation.



Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.

©2019 Transparency Market Research, All Rights Reserved



Regulatory stance of the FDA towards clearing uveitis drugs from the pipelines is improving, and market players are being favored to introduce novel administration techniques for ocular inflammation treatments.



During the period of assessment, 2017-2026, the global market for ocular inflammation treatments is pegged to expand at a CAGR of 6.9% in terms of value.



In addition to Allergan, TMR also observes high stakes of Novartis AG, Valeant Pharmaceuticals International, Inc., Abbvie, Inc., Alimera Sciences, Inc., Eyegate Pharmaceuticals, Inc., pSivida Corp., Pfizer, Inc., Cipla Ltd., and Akorn, Inc. in the global ocular inflammation treatment market over the coming years.

©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com

Thank You

Š2019 Transparency Market Research, All Rights Reserved